News

KARACHI: Saad Z Usmani a graduate of the Allama Iqbal Medical College Lahore, working with the Memorial Sloan Kettering Cancer Centre New York, USA, brings honors for Pakistan by becoming the first ...
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...
Who wore what best? Step onto the annual Viennese Opera Ball, a dazzling gala that unites Austrian and American culture in ...
Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.
This is a proof of concept that we can repair parts of the brain, to give it new life and function, which opens the door to other neurological disorders,” says Viviane Tabar, a stem cell ...
Scientific Advisory Board (SAB) of clinical and scientific experts to advise it on its products designed to maximize the ...
New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...
Yelena Y. Janjigian, MD, discusses how to manage the potential adverse events of pembrolizumab when using the recently ...
According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.
Two small studies published recently in Nature offer early but important validation that stem cell treatments for Parkinson’s disease are viable.
With a 95% retention rate for nurse residents completing the program and a 100% 2-year post-hire retention rate, these initiatives ensure a stable and well-trained workforce.